Pearl Freier, Founder of Cambridge BioPartners, shared a recent article by on X:
“AI tools to improve diagnosis and therapy in neuro-oncology are increasing and The Lancet Oncology review provides an assessment of the field with focus on Artificial Intelligence for Response Assessment in Neuro Oncology.
AI models of key genomic markers and predictive AI models of response before and after therapy.”
Authors: Spyridon Bakas, Janine M Lupo, Evan Calabrese, Christos Davatzikos, Wenya Linda Bi, Marwa Ismail, Hamed Akbari, Philipp Lohmann, Thomas C Booth, Benedikt Wiestler, Hugo J W L Aerts, Ghulam Rasool, Joerg C Tonn, Martha Nowosielski, Rajan Jain, Rivka R Colen, Sarthak Pati, Ujjwal Baid, Philipp Vollmuth, David Macdonald, Michael A Vogelbaum, Susan M Chang, Raymond Y Huang and Norbert Galldiks
For more updates, follow OncoDaily.